Please ensure Javascript is enabled for purposes of website accessibility
Revamped OxyContin Was Supposed to Reduce Abuse, but Has It?
gvw_ap_news
By Associated Press
Published 6 years ago on
July 22, 2019

Share

WASHINGTON — Dr. Raeford Brown was uniquely positioned to help the U.S. government answer a critical question: Is a new version of the painkiller OxyContin helping fight the national opioid epidemic?
An expert in pain treatment at the University of Kentucky, Brown led a panel of outside experts advising the Food and Drug Administration on opioids that have been reformulated to deter snorting and injecting.
There’s just one problem: Neither the company that makes OxyContin nor the FDA has allowed the experts to see data on whether it reduces abuse.

“It’s in the public interest that we all know what these drugs are doing and yet none of us can see it, which is really terrifying when you think about it.” — Dr. Raeford Brown, University of Kentucky
“We asked for that data probably 40 or 50 times in last four or five years and were denied every time,” said Brown, whose term as an FDA adviser ended in March.
Nearly a decade ago, the FDA approved reformulated OxyContin and told the company, Purdue Pharma, that it would be evaluated on whether the new version decreased cases of addiction, overdose and death. The data submitted by Purdue to answer that question remains secret.
“It’s in the public interest that we all know what these drugs are doing and yet none of us can see it, which is really terrifying when you think about it,” Brown told The Associated Press.
In 2015, Brown and his colleagues were supposed to review follow-up data on OxyContin at a meeting in Washington, but the FDA canceled it only days before. Purdue had pulled its application to update OxyContin’s label with new information on abuse, saying it wanted more time to analyze the data. Such meetings are typically planned months in advance and are almost never canceled.
A Purdue spokesman said the Stamford, Connecticut-based company has been working to complete four updated study requirements assigned by the FDA in 2016. Purdue expects to complete that work this year.
But the FDA’s top staffer for opioids said at a public meeting last year that the agency expected the information to become available “years ago.”
“They have it, but it’s hard for us to force them to submit it,” said Sharon Hertz, FDA’s division director for pain medications.
The unreleased OxyContin data highlights the FDA’s precarious role as both a public health agency and close confidante of industry. While the agency can order a drugmaker to research important questions, the information itself still belongs to the company and is deemed “confidential commercial information.”
An FDA spokeswoman said in an email that it would be “premature” to comment on Purdue’s results before they have been fully submitted and reviewed. The agency noted that the company’s final OxyContin study has been delayed. FDA staffers expect the studies “will help us understand the real-world impact of OxyContin’s reformulation on abuse,” said Lyndsay Meyer.

Overdose Deaths

If OxyContin has reduced overdose deaths, federal statistics don’t show it.
OxyContin remains the best-selling opioid brand in the country, but it accounts for less than 2 percent of U.S. opioid prescriptions, potentially limiting its impact on national trends. (Most opioids prescribed are low-priced generic pills.)
Since the new formulation was approved in 2010, fatal overdoses involving prescription opioids including OxyContin, Percocet and generic pills have risen more than 30 percent to about 14,500 in 2017, the most recent year for which complete data is available. Preliminary figures released last week suggest drug-related deaths likely fell last year for the first time in decades.
Some researchers have suggested reformulated OxyContin, combined with tighter prescribing and other measures, accelerated the nationwide shift toward heroin and fentanyl. Those drugs were involved in more than 43,000 overdose deaths in 2017, nearly three times the number as prescription opioids.
The FDA has now approved seven opioids, including OxyContin, with labeling that they are “expected” to discourage abuse.
Those pills are intended to be difficult to crush, break or dissolve, but they can still be misused when simply swallowed. And the drugs carry the same addiction risks.
“The real problem with opioids from the public health perspective is addiction,” said Dr. Lewis Nelson, a Rutgers University emergency medical specialist who also serves as an FDA adviser. “These pills in the reformulated version don’t do anything to reduce the likelihood or magnitude of addiction.”
Purdue has published preliminary information on reformulated OxyContin in peer-reviewed journals, but the studies are clouded by potential biases and limitations. Many are written by Purdue scientists or researchers whose work is funded by the company. In most cases, the data comes from a network of specialized sources, including poison control centers, law enforcement records and drug rehabilitation clinics.

Photo of OxyContin pill bottles
Containers depicting OxyContin prescription pill bottles lie on the ground in front of the Department of Health and Human Services’ headquarters in Washington during an April protest against the FDA’s opioid prescription drug approval practices. (AP Photo/Patrick Semansky, File)
Those sources show a positive picture for OxyContin’s performance, with key indicators like emergency calls, law enforcement reports and rates of patients seeking prescriptions from multiple prescribers — known as doctor shopping — dropping.
But even the study authors acknowledge that those measures don’t necessarily reflect what’s happening across the country. Only a small segment of people misusing opioids ever enter rehabilitation, for instance.
When FDA researchers decided to independently examine OxyContin abuse in a study using a much larger dataset — a federal government annual survey — they found a different picture. Among people with a history of misusing prescription opioids, rates of OxyContin abuse were similar or higher three years after the drug was reformulated.
“If you were going to see an impact, this is the population where you should see it. And we didn’t see anything,” said Dr. Christopher Jones, who co-authored the 2017 paper and now works at the Centers for Disease Control and Prevention.
The paper’s findings square with survey results suggesting less than 5% of long-term abusers gave up OxyContin after it was reformulated.
Garrett Hade of Los Angeles said that when he was addicted to opioids it would take him only a few minutes in his kitchen to prepare OxyContin for injecting.
“It just became a matter of ‘this is what you have to do today because you have abuse-deterrent OxyContin,'” said Hade, 32, who is in recovery.

Continuing Cost of Oxycontin

First launched in 1996, the original OxyContin helped spark a wave of abuse as some people quickly learned to crush the long-acting pills to release a massive opioid dose. Under pressure from regulators, politicians and law enforcement, Purdue reformulated the painkiller in 2010.
Government data unveiled last week showed Purdue and other drugmakers flooded the U.S. with more than 76 billion opioid pills between 2006 and 2012. Areas that received the most pills also had the highest overdose rates.
Today, Purdue faces some 2,000 local and state lawsuits alleging its aggressive marketing contributed to the opioid epidemic by downplaying OxyContin’s addiction risks and promoting the drug for common pain ailments. The lawsuits have pushed the company to publicly discuss bankruptcy.

Today, Purdue faces some 2,000 local and state lawsuits alleging its aggressive marketing contributed to the opioid epidemic by downplaying OxyContin’s addiction risks and promoting the drug for common pain ailments.
The reformulation has been good for business.
The patent on original OxyContin would have expired in 2013, allowing lower-priced generics to gobble up Purdue’s market share. By reformulating the drug, Purdue was able to extend its patent until 2030.
Since 2010, OxyContin has generated more than $21 billion in U.S. sales, according to pharmaceutical tracking service IQVIA.
Purdue viewed the anti-abuse reformulation as a “key driver” of new prescriptions and stressed the features in promotions to doctors, according to its marketing materials. Purdue stopped promoting OxyContin directly to doctors last year amid mounting scrutiny.
Meanwhile Purdue has steadily increased OxyContin’s price more than 95 percent, to $22 per pill for the drug’s highest dose, according to data firm Elsevier.
Whether the drug’s anti-abuse features warrant those costs has been debated.
The nonprofit group Institute for Clinical and Economic Review has found mixed evidence for OxyContin’s ability to fight abuse.
Dr. Peter Lurie, a former FDA senior official, co-authored the 2017 paper that found OxyContin misuse was essentially unchanged among long-term users.
Now president of the nonprofit Center for Science in the Public Interest, Lurie notes that OxyContin is by far the most prescribed and most studied abuse-deterrent opioid.
“If we can’t prove it for OxyContin, how are we going to show it for anything else?” he asked.

DON'T MISS

What Are Fresno Real Estate Experts Predicting for 2025 and Beyond?

DON'T MISS

First California EV Mandates Hit Automakers This Year. Most Are Not Even Close

DON'T MISS

Vacant Fresno Restaurant Heavily Damaged in Early Morning Fire

DON'T MISS

Visalia Police Make Arrest in Deadly Hit-and-Run

DON'T MISS

Madera County Inmate Arrested After Chase and Crash With Kids in Car

DON'T MISS

Fresno Shooting Leaves Man Dead Near Griffith and Hughes

DON'T MISS

Iran and Israel Say a New Wave of Iranian Missile Attacks Has Begun. Explosions Heard Over Jerusalem

DON'T MISS

Man Found Dead in Bass Lake, Cause Under Investigation

DON'T MISS

US Marines Carry out First Known Detention of Civilian in Los Angeles, Video Shows

DON'T MISS

Tensions Boil Between Arias and Dem Congressmembers

DON'T MISS

ICE Arrests of Non-Criminal Migrants Surge 800% Under Trump

DON'T MISS

Youth Invited to Unplug, Connect With Nature at Day Camp in Auberry

UP NEXT

US House Passes Trump Cuts of $9.4 Billion for Foreign Aid, Broadcasting

UP NEXT

Tulare County Inmate Found Unresponsive in Cell, Autopsy Pending

UP NEXT

Harvey Weinstein Convicted of Sex Crime Amid Contentious Jury Deliberations

UP NEXT

Trump Warns Protests at Army Parade Will Be Met With Force

UP NEXT

Do Americans Support Trump’s Use of Marines in LA? The Numbers Might Shock You

UP NEXT

Marines Will Deploy to LA for 60 Days, Costing Taxpayers $134 Million

UP NEXT

First the National Guard, Will the Marines Be Next at LA Riots?

UP NEXT

Sights & Sounds: The 2025 Fresno Rainbow Pride Parade and Festival

UP NEXT

Doctors Were Preparing to Remove Their Organs. Then They Woke Up.

UP NEXT

FDA’s AI Assistant ‘Elsa’ Fails Its First Day on the Job

Fresno Shooting Leaves Man Dead Near Griffith and Hughes

10 hours ago

Iran and Israel Say a New Wave of Iranian Missile Attacks Has Begun. Explosions Heard Over Jerusalem

11 hours ago

Man Found Dead in Bass Lake, Cause Under Investigation

11 hours ago

US Marines Carry out First Known Detention of Civilian in Los Angeles, Video Shows

11 hours ago

Tensions Boil Between Arias and Dem Congressmembers

11 hours ago

ICE Arrests of Non-Criminal Migrants Surge 800% Under Trump

11 hours ago

Youth Invited to Unplug, Connect With Nature at Day Camp in Auberry

12 hours ago

Mexico’s Sheinbaum Urges US to Avoid Immigration Action at LA Soccer Game

12 hours ago

Fresno County’s Firestone Fire Grows, Personnel Added to Contain the Blaze

13 hours ago

Valley Crime Stoppers’ Most Wanted Person of the Day: Allan Saly

13 hours ago

Vacant Fresno Restaurant Heavily Damaged in Early Morning Fire

An early morning fire caused significant damage to a vacant restaurant building in Fresno, the Fresno Fire Department reported.   ...

9 hours ago

A vacant Fresno restaurant was heavily damaged in a fire early Friday, June 13, 2025, morning, with no injuries reported and the cause under investigation. (Fresno FD)
9 hours ago

Vacant Fresno Restaurant Heavily Damaged in Early Morning Fire

10 hours ago

Visalia Police Make Arrest in Deadly Hit-and-Run

Michael Sanchez, 30, a Madera County inmate, who failed to return from a funeral day-pass was arrested Friday after a police chase and crash involving children. (Madera County SO)
10 hours ago

Madera County Inmate Arrested After Chase and Crash With Kids in Car

10 hours ago

Fresno Shooting Leaves Man Dead Near Griffith and Hughes

Israeli Iron Dome air defense system fires to intercept missiles over Tel Aviv, Israel, Friday, June 13, 2025. (AP Photo/Tomer Neuberg)
11 hours ago

Iran and Israel Say a New Wave of Iranian Missile Attacks Has Begun. Explosions Heard Over Jerusalem

A man in his 80s was found dead in Bass Lake on Friday, June 13, 2025, morning while attempting to launch a boat, authorities said. (Madera County SO)
11 hours ago

Man Found Dead in Bass Lake, Cause Under Investigation

U.S. Marines detain a person outside the Wilshire Federal Building after Marines were deployed to Los Angeles, as protests against federal immigration sweeps continue, in Los Angeles, California, U.S. June 13, 2025. (Reuters/Aude Guerrucci)
11 hours ago

US Marines Carry out First Known Detention of Civilian in Los Angeles, Video Shows

11 hours ago

Tensions Boil Between Arias and Dem Congressmembers

Help continue the work that gets you the news that matters most.

Search

Send this to a friend